CELZ CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CIK 0001187953 27 ready 8-Ks latest July 2, 2026, 4:15 PM ET RSS · JSON

Activity: NORMAL 1 filings / 30d vs 0 baseline

Ready 8-Ks 27

Latest filing August 31, 2026, 4:05 PM ET

Top materiality 0.75

Event mix other_material ×18 · other ×3 · regulatory ×3

Sentiment 2 pos · 2 neg · 23 neu

Executive change recent →

SHENANIGAN SCORE 1 / 7 see the board

Recent 8-K filings for CELZ

Highest-materiality recent filing

Creative Medical regains Nasdaq minimum bid price compliance after 10-day stretch above $1.00

June 28, 2023, 7:59 PM ET regulatory materiality 0.75 positive item 8.01 item 9.01

Received Nasdaq notice on June 27, 2023 that it regained compliance with Listing Rule 5550(a)(2).
Closing bid price exceeded $1.00 for 10 consecutive trading days (June 12–26, 2023).

Read filing →

July 2, 2026, 4:15 PM ET other material materiality 0.60 neutral item 1.01 item 3.02 item 5.02 item 9.01

Creative Medical raises ~$4.5M via warrant exercise inducement; issues new warrants for 5.58M shares

Existing warrants for 2.79M shares exercised at reduced price of $1.60/share, raising ~$4.5M gross proceeds.
October 31, 2025, 7:59 PM ET other material materiality 0.70 neutral item 1.01 item 3.02 item 9.01 ◈ Equity Issuances

CELZ raises ~$4.2M via warrant exercise inducement; issues 2.79M new warrants

Holders of 1,116,136 warrants exercised at $3.75/share, yielding $4.2M gross proceeds.
March 7, 2025, 6:59 PM ET other material materiality 0.65 neutral item 1.01 item 3.02 item 9.01

Creative Medical Technology raises $3.7M via warrant exercise inducement; issues new warrants at $3.75

Gross proceeds of ~$3.7M from cash exercise of 837,104 existing warrants at $4.42/share.
December 26, 2024, 6:59 PM ET other material materiality 0.60 neutral item 5.03 item 5.07 item 9.01 ◈ Governance Changes

Shareholders vote to increase authorized shares from 5M to 25M, approve warrant exercise

Authorized common shares increased from 5M to 25M via Certificate of Amendment filed Dec 19, 2024.
October 23, 2024, 7:59 PM ET other material materiality 0.60 neutral item 1.01 item 9.01

CELZ raises $1.85M in registered direct offering of shares and warrants

Gross proceeds ~$1.85M; net ~$1.6M after fees and expenses; proceeds for working capital.
June 28, 2023, 7:59 PM ET regulatory materiality 0.75 positive item 8.01 item 9.01

Creative Medical regains Nasdaq minimum bid price compliance after 10-day stretch above $1.00

Received Nasdaq notice on June 27, 2023 that it regained compliance with Listing Rule 5550(a)(2).
June 9, 2023, 7:59 PM ET other material materiality 0.60 neutral item 3.03 item 5.03 item 8.01 item 9.01 ◈ Governance Changes

Creative Medical Technology announces 1-for-10 reverse stock split effective June 12, 2023 to regain Nasdaq compliance

Reverse split ratio 1-for-10; outstanding shares reduced from ~14.1M to ~1.4M.
July 14, 2022, 7:59 PM ET regulatory materiality 0.65 negative item 3.01

Creative Medical receives Nasdaq deficiency notice for bid price below $1.00

Nasdaq notice for non-compliance with Listing Rule 5550(a)(2) due to bid price below $1.00 for 30 consecutive days.
May 4, 2022, 7:59 PM ET other material materiality 0.70 neutral item 1.01 item 3.02 item 9.01

Creative Medical raises ~$17M in private placement with institutional investors

Company sold 2,991,669 shares, 4,563,887 pre-funded warrants ($0.0001 exercise), and 15,111,112 common warrants ($2.00; 5-year term) at $2.25 per combined unit.
May 4, 2022, 7:59 PM ET other material materiality 0.75 neutral item 1.01 item 3.02 item 9.01

Creative Medical raises $17M in PIPE with shares, pre-funded & common warrants

Gross proceeds ~$17M from sale of 2,991,669 shares, pre-funded warrants for 4,563,887 shares, and common warrants for 15,111,112 shares at $2.25/unit.
December 7, 2021, 6:59 PM ET other material materiality 0.75 positive item 1.01 item 3.01 item 5.02 item 9.01 ◈ executive_change ×5

Creative Medical Technology Holdings prices $16M public offering, uplists to Nasdaq, appoints new directors

Priced 3.875M shares and warrants at $4.13 per combined unit; gross proceeds ~$16M.
November 9, 2021, 6:59 PM ET other material materiality 0.70 neutral item 3.03 item 5.03 item 8.01 item 9.01

Creative Medical announces 1-for-500 reverse stock split; authorized shares cut to 50M

Reverse split at 1:500 effective Nov 10, 2021; outstanding shares reduced from ~1.23B to ~2.45M.
November 5, 2021, 7:59 PM ET other material materiality 0.65 neutral item 3.03 item 5.03 item 9.01

Creative Medical increases authorized common shares from 6B to 25B; withdraws Series B and C Preferred designations

Authorized common shares increased from 6,000,000,000 to 25,000,000,000 via Certificate of Amendment filed Nov 2, 2021.